These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35881420)
1. Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study. Mancia G; Facchetti R; Quarti-Trevano F; Grassi G J Hypertens; 2022 Oct; 40(10):1909-1917. PubMed ID: 35881420 [TBL] [Abstract][Full Text] [Related]
2. Effect of long-term antihypertensive treatment on white-coat hypertension. Mancia G; Facchetti R; Parati G; Zanchetti A Hypertension; 2014 Dec; 64(6):1388-98. PubMed ID: 25245386 [TBL] [Abstract][Full Text] [Related]
3. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index. Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516 [TBL] [Abstract][Full Text] [Related]
4. Health football beats them all: subgroup analysis of the 3F (Fit&Fun with Football) study on white-coat hypertension, sustained hypertension, dippers, nondippers, and on pharmacologically un(treated) arterial hypertension. Schrader B; Conradi C; Lüders S; Vaske B; Koziolek M; Gehlenborg E; Haller H; Elsässer A; Schrader J J Hypertens; 2023 Apr; 41(4):564-571. PubMed ID: 36729435 [TBL] [Abstract][Full Text] [Related]
5. Comparison of office, home and ambulatory blood pressure measurements in hypertensive and suspected hypertensive SWICOS participants. Radovanovic D; Muggli F; Bianchetti M; Gallino A; Parati G; Suter PM; Schoenenberger-Berzins R; Erne P; Schoenenberger AW Blood Press; 2023 Dec; 32(1):2234496. PubMed ID: 37452435 [TBL] [Abstract][Full Text] [Related]
6. Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy. Agarwal R; Weir MR J Am Soc Hypertens; 2013; 7(3):236-43. PubMed ID: 23523137 [TBL] [Abstract][Full Text] [Related]
7. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension. Mancia G; Facchetti R; Grassi G; Bombelli M Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342 [TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584 [TBL] [Abstract][Full Text] [Related]
9. Lifestyle Behaviors Among Adults Recommended for Ambulatory Blood Pressure Monitoring According to the 2017 ACC/AHA Blood Pressure Guideline. Cohen LP; Hubbard D; Colvin CL; Jaeger BC; Poudel B; Abdalla M; Langford AT; Hardy ST; Sims M; Lewis CE; Muntner P; Shimbo D Am J Hypertens; 2021 Nov; 34(11):1181-1188. PubMed ID: 34270687 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators. Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of blood pressure phenotypes identified by office and ambulatory blood pressure in treated hypertensive patients. Data from the PHYLLIS study. Mancia G; Facchetti R; Vanoli J; Dolfini V; Grassi G Hypertens Res; 2022 Oct; 45(10):1599-1608. PubMed ID: 35941356 [TBL] [Abstract][Full Text] [Related]
12. Current status of white coat hypertension: where are we? Nuredini G; Saunders A; Rajkumar C; Okorie M Ther Adv Cardiovasc Dis; 2020; 14():1753944720931637. PubMed ID: 32580646 [TBL] [Abstract][Full Text] [Related]
13. A commentary on the article 'Antihypertensive drug treatment in white-coat hypertension: data from the Plaque Hypertension Lipid-Lowering Italian Study'. Hitij JB J Hypertens; 2022 Oct; 40(10):1897-1898. PubMed ID: 36052519 [No Abstract] [Full Text] [Related]
14. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population. Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885 [TBL] [Abstract][Full Text] [Related]
15. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial. Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A; Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192 [TBL] [Abstract][Full Text] [Related]
16. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. Mancia G; Parati G; Revera M; Bilo G; Giuliano A; Veglia F; Crepaldi G; Zanchetti A BMJ; 2010 Mar; 340():c1197. PubMed ID: 20339154 [TBL] [Abstract][Full Text] [Related]
17. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis. Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension. Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777 [TBL] [Abstract][Full Text] [Related]
19. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group. Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308 [TBL] [Abstract][Full Text] [Related]
20. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]